EGFR and colorectal carcinoma: Examples of critical RTKs in CRC include EGFR, VEGFR, PDGFR, IGFR, and FGFRs, with both specific RTK inhibitors and multi-kinase inhibitors used to target them in patients with metastatic CRC (reviewed in [10]).